Highlights ANGLE plc

Equities

Market Closed - London S.E. Other stock markets 11:35:07 2024-05-15 EDT			5-day change	1st Jan Change
23.25 ^GBX	+9.41%		+9.41%	+97.87%

05-03	Angle shares up on assay development deal with AstraZeneca	AN
05-03	Angle shares up on assay development deal with AstraZenaca	AN

Angle shares up on assay development deal with AstraZeneca	05-03	AN
Angle shares up on assay development deal with AstraZenaca	05-03	AN
Angle Plc to Supply Prostate Cancer Androgen Receptor Detection Assay to AstraZeneca	05-03	MT
AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal	05-03	AN
Confident start before US jobs data	05-03	AN
InterContinental Hotels makes first-quarter progress	05-03	AN
ANGLE plc Announces New Commercial Agreement with Large Pharma	05-03	CI
No record close for FTSE 100; mixed trade in US	04-24	AN
No record close for FTSE 100; mixed trade in US	04-24	AN
Angle plc to Develop New Cancer Assay in Deal with AstraZeneca	04-24	MT
Angle shares jump on supplier agreement with with AstraZeneca	04-24	AN
Angle PLC Announces New Commercial Agreement with AstraZeneca PLC	04-24	CI
Angle granted patents in US and Europe for Cellkeep slide	04-22	AN
Angle plc Secures European Patent for CellKeep Technology	04-22	MT
ANGLE plc Presents Parsortix HER2 Assay at AACR Annual Meeting 2024	04-08	CI
Angle highlights supportive data for DNA analysis tool	01-22	AN
ANGLE plc Announces Clinical Results Provide A Unique Insight into the Progression of Each Patient's Cancer	01-04	CI
Angle PLC Shares Rise on Cancer Patient Blood Sample Analysis	01-04	DJ
Angle teams with Japan's Eisai in breast cancer drug trial	01-02	AN
Angle plc Signs Contract with Eisai on Breast Cancer Study	01-02	MT

No results for this search